According to the report, the global digital breast tomosynthesis market is projected to grow at a CAGR of 14% between 2024 and 2032 reaching a value of approximate USD 11.8 Billion by 2032. Aided by the escalating need for advanced breast cancer diagnostic tools and the growing awareness of early detection, the market is expected to grow significantly by 2032.
Digital Breast Tomosynthesis, often referred to as 3D mammography, is an innovative imaging technique designed to pinpoint and diagnose breast cancer with superior accuracy compared to traditional mammograms. This modality operates by capturing multiple images of the breast from varying angles, generating a comprehensive three-dimensional representation of the breast tissue. Such precise imaging has led to a significant reduction in false positives and enhanced tumour detection, especially in dense breast tissues.
The surge in breast cancer incidence worldwide is catalysing the digital breast tomosynthesis market demand. A global uptick in health consciousness and the persistent emphasis on early breast cancer detection have resulted in an increased number of women opting for regular mammography screenings. These factors, combined with the limitations of traditional mammography in detecting tumours in dense breasts, have led to the growing preference for DBT.
Additionally, the widespread integration of artificial intelligence (AI) and advanced software tools in the realm of medical imaging has significantly elevated the capabilities of DBT. These advancements provide radiologists with clearer images and aid in the easier detection and differentiation of benign and malignant masses, consequently enhancing diagnostic accuracy.
As per the digital breast tomosynthesis market analysis, medical practitioners and health institutions are progressively recognising the potential of DBT in supplementing or even replacing conventional mammography. The increased detection rate of invasive breast cancers, coupled with a reduction in the recall rates for additional imaging, underscores the efficacy of DBT, driving its adoption across diagnostic centres and hospitals globally.
Moreover, global health bodies and breast cancer advocacy groups are aggressively promoting early and regular breast screenings. These campaigns, bolstered by numerous success stories highlighting the crucial role of early detection in positive patient outcomes, further advocate the superiority of DBT over traditional methods, which, in turn, bolster the digital breast tomosynthesis market growth.
Furthermore, with the continuous advancements in medical technology, the incorporation of DBT into handheld devices and portable screening units is on the horizon. Such innovations are expected to enhance accessibility and affordability, paving the way for more widespread adoption of DBT, especially in regions with limited access to advanced medical facilities.
Digital Breast Tomosynthesis, often referred to as 3D mammography, is an innovative imaging technique designed to pinpoint and diagnose breast cancer with superior accuracy compared to traditional mammograms. This modality operates by capturing multiple images of the breast from varying angles, generating a comprehensive three-dimensional representation of the breast tissue. Such precise imaging has led to a significant reduction in false positives and enhanced tumour detection, especially in dense breast tissues.
The surge in breast cancer incidence worldwide is catalysing the digital breast tomosynthesis market demand. A global uptick in health consciousness and the persistent emphasis on early breast cancer detection have resulted in an increased number of women opting for regular mammography screenings. These factors, combined with the limitations of traditional mammography in detecting tumours in dense breasts, have led to the growing preference for DBT.
Additionally, the widespread integration of artificial intelligence (AI) and advanced software tools in the realm of medical imaging has significantly elevated the capabilities of DBT. These advancements provide radiologists with clearer images and aid in the easier detection and differentiation of benign and malignant masses, consequently enhancing diagnostic accuracy.
As per the digital breast tomosynthesis market analysis, medical practitioners and health institutions are progressively recognising the potential of DBT in supplementing or even replacing conventional mammography. The increased detection rate of invasive breast cancers, coupled with a reduction in the recall rates for additional imaging, underscores the efficacy of DBT, driving its adoption across diagnostic centres and hospitals globally.
Moreover, global health bodies and breast cancer advocacy groups are aggressively promoting early and regular breast screenings. These campaigns, bolstered by numerous success stories highlighting the crucial role of early detection in positive patient outcomes, further advocate the superiority of DBT over traditional methods, which, in turn, bolster the digital breast tomosynthesis market growth.
Furthermore, with the continuous advancements in medical technology, the incorporation of DBT into handheld devices and portable screening units is on the horizon. Such innovations are expected to enhance accessibility and affordability, paving the way for more widespread adoption of DBT, especially in regions with limited access to advanced medical facilities.
Market Segmentation
The market can be divided based on product, application, and region.Market Breakup by Product
- 2D/3D Combination Systems
- Standalone 3D Systems
Market Breakup by Application
- Hospitals
- Diagnostic Centres
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Competitive Landscape
The report looks into the market shares, plant turnarounds, capacities, investments, and mergers and acquisitions, among other major developments, of the leading companies operating in the global digital breast tomosynthesis market. Some of the major players explored in the report are as follows:- Hologic, Inc. (NASDAQ: HOLX)
- Varex Imaging Corporation
- GE Healthcare
- Siemens Healthineers AG (ETR: SHL)
- Fujifilm Corporation
- PerkinElmer Inc.
- Others
Table of Contents
1 Preface2 Report Coverage - Key Segmentation and Scope4 Key Assumptions7 Industry Opportunities and Challenges12 Industry Events and Developments
3 Report Description
5 Executive Summary
6 Snapshot
8 Global Digital Breast Tomosynthesis Market Analysis
9 Regional Analysis
10 Market Dynamics
11 Competitive Landscape
List of Key Figures and Tables
Companies Mentioned
- Hologic Inc. (HOLX :NASDAQ)
- Ge Healthcare
- Siemens Healthineers AG(SHL:ETR)
- Fujifilm Corporation
- PerkinElmer Inc.
Methodology
LOADING...
